✨ SON, Sponsor of the Innovative Drugs Master Program for 2024-2025 ✨

We are very pleased to announce our role as sponsor of the Innovative Drugs Master Program, an innovative pharmaceutical sciences program with high level students.

This international Master is based in France. 

▶ The International Master’s Program in Innovative Drugs, co-directed by Arnaud Beduneau and Bertrand Collin, welcomes students from all over the world.

▶ The program is supported by leading institutional partners such as the University of Burgundy and the University of Franche-Comté, through their Faculties of Health Sciences (Dijon) and Health (Besançon).

▶ Funding is provided by the LabEx LIPSTIC and EquipEx IMAPPI, along with the graduate schools One Health and Intherapi. Dijon Métropole and Santenov also offer vital support, contributing to the healthcare economy.

▶ Partner laboratories and hospitals, play a key role in the success of the program by providing students with an environment conducive to innovation and applied research.

▶ Finally, we would like to congratulate the teachers who guide, train, and nurture these brilliant students. Without them, nothing would be possible.

For more information, check out our article on the SON website https://www.sonsas.com/en/news/son-becomes-the-sponsor-of-the-master-innovative-drugs/